The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective comparison of long-term outcomes in patients with stage II/III (UICC-TNM6th) esophageal squamous cell carcinoma treated with 60 Gy or 50.4 Gy of definitive chemoradiotherapy with fluorouracil and platinum.
 
Hidekazu Hirano
No Relationships to Disclose
 
Ken Kato
No Relationships to Disclose
 
Shoko Nakamura
No Relationships to Disclose
 
Yusuke Sasaki
No Relationships to Disclose
 
Naoki Takahashi
No Relationships to Disclose
 
Satoru Iwasa
No Relationships to Disclose
 
Yoshitaka Honma
No Relationships to Disclose
 
Natsuko Okita
No Relationships to Disclose
 
Atsuo Takashima
No Relationships to Disclose
 
Tetsuya Hamaguchi
No Relationships to Disclose
 
Yoshinori Ito
No Relationships to Disclose
 
Jun Itami
No Relationships to Disclose
 
Narikazu Boku
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)